Salvage Therapy

For many patients with AML, initial treatments fail to achieve remission. If your AML doesn’t respond to induction therapy (refractory disease), or if you achieve remission and then experience a relapse (relapsed disease), you may be offered salvage therapy.

For patients with recurrent AML, salvage therapy may involve further rounds of chemotherapytargeted therapy, or arsenic trioxide therapy. There are also a number of medications developed especially for patients with relapsed AML. Some patients who need salvage therapy enrol in a clinical trial designed for treatment of resistant or relapsed disease. Depending on your age and disease type, you may also be offered stem cell transplantation.  


Join Our Community Register for Events Read Our Latest Blog

Page last updated on April 3, 2017